Dr. Dhawan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2557 Mowry Ave
Ste 34
Fremont, CA 94538Phone+1 510-797-4111Fax+1 510-797-3320
Education & Training
- Mount Sinai Medical Center of Florida, IncResidency, Dermatology, 1987 - 1990
- University of California (San Francisco)/Mount ZionResidency, Internal Medicine, 1983 - 1986
- Keck School of Medicine of the University of Southern CaliforniaClass of 1983
Certifications & Licensure
- CA State Medical License 1984 - 2026
- FL State Medical License 1987 - 1998
- American Board of Dermatology Dermatology
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Top MD Consumers Checkbook
- Fellow (FAAD) American Academy of Dermatology
Clinical Trials
- A Comparison of DFD01 Spray Versus Comp01 Lotion, Vehicle Spray and Vehicle Lotion in Subjects With Moderate Psoriasis Start of enrollment: 2013 Nov 01
- VPD-737 for Treatment of Chronic Pruritus Start of enrollment: 2013 Oct 15
- Comparator Study of the Effect of Glycopyrrolate and Glycopyrronium in Subjects With Axillary Hyperhidrosis Start of enrollment: 2014 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 5 citationsImportance of treating acne sequelae in skin of color: 6-month phase IV study of trifarotene with an appropriate skincare routine including UV protection in acne-induc...Andrew Alexis, James Q Del Rosso, Seth Forman, Antonio Martorell, John Browning
International Journal of Dermatology. 2024-06-01 - 1 citationsEffect of NFX-179 MEK inhibitor on cutaneous neurofibromas in persons with neurofibromatosis type 1.Kavita Y Sarin, Mark Bradshaw, Chris O'Mara, Jahanbanoo Shahryari, John Kincaid
Science Advances. 2024-05-03 - Correction: Trifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled Study.Stephen Schleicher, Angela Moore, Elyse Rafal, Angelique Gagne-Henley, Sandra Marchese Johnson
Dermatology and Therapy. 2024-02-01
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: